Amarin Corp Plc (AMRN)

[KCSVEN]

They will very likely update guidance at the next earnings release. It would be unusual to do it in between, it's normally done with earnings releases.

JT did say
"Such guidance assumes that the approved label for Vascepa is not expanded by the FDA during 2019. "

It's possible they do not raise guidance until after FDA approval but logically they would update guidance slightly with the caveat it assumes label expansion by FDA in September.

They are clearly graduates of the Steve Jobs sandbagging academy and that is not a bad thing long term but they need more acceleration in revenues and higher beats before it will reflect in stock price. Better to be conservative than give a real best estimate and come up short.

We are less than 4 months away from when, as JT said, the "exciting" part starts to happen.